These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 3198153)

  • 1. Effect of magnesium and pyridoxine supplementation on glycolate induced hyperoxaluria in male albino rats.
    Gulati S; Narula R; Sadhna S; Sidhu H; Wangoo D; Thind SK; Nath R
    Indian J Exp Biol; 1988 Jul; 26(7):525-7. PubMed ID: 3198153
    [No Abstract]   [Full Text] [Related]  

  • 2. Pyridoxine and dietary counseling for the management of idiopathic hyperoxaluria in stone-forming patients.
    Ortiz-Alvarado O; Miyaoka R; Kriedberg C; Moeding A; Stessman M; Monga M
    Urology; 2011 May; 77(5):1054-8. PubMed ID: 21334732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of pyridoxine supplementation on recurrent stone formers.
    Murthy MS; Farooqui S; Talwar HS; Thind SK; Nath R; Rajendran L; Bapna BC
    Int J Clin Pharmacol Ther Toxicol; 1982 Sep; 20(9):434-7. PubMed ID: 7141762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pyridoxine can normalize oxaluria in idiopathic renal lithiasis].
    Jaeger P; Portmann L; Jacquet AF; Burckhardt P
    Schweiz Med Wochenschr; 1986 Dec; 116(50):1783-6. PubMed ID: 3798070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the effect of triterpenes on urinary risk factors of stone formation in pyridoxine deficient hyperoxaluric rats.
    Vidya L; Lenin M; Varalakshmi P
    Phytother Res; 2002 Sep; 16(6):514-8. PubMed ID: 12237806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prophylactic treatment of oxalate calculi].
    Ljunggren E
    Z Urol Nephrol; 1965 Jul; 58(7):507-12. PubMed ID: 5841716
    [No Abstract]   [Full Text] [Related]  

  • 7. [Possibilities of pharmacological prevention of oxalate calculi].
    Terhorst B; Lutzeyer W
    Z Urol Nephrol; 1972 Nov; 65(11):815-25. PubMed ID: 4665913
    [No Abstract]   [Full Text] [Related]  

  • 8. [Urolithiasis. Biochemical aspects].
    Malm OJ
    Tidsskr Nor Laegeforen; 1968 Mar; 88(6):532-5. PubMed ID: 4970175
    [No Abstract]   [Full Text] [Related]  

  • 9. [A new drug in the therapy of uric acid calculi].
    Frang D; Berényi M; Babics A
    Z Urol Nephrol; 1974 Feb; 67(2):89-92. PubMed ID: 4847955
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effects of mangesium salts and their combinations with vitamin B6 on oxalates crystalluria in rats fed with pyridoxine-deficient diet].
    Spasov AA; Iezhitsa IN; Kharitonova MV; Kravchenko MS
    Urologiia; 2009; (3):22-5. PubMed ID: 19670811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Drug prevention of recurring urolithiasis].
    Böwering R
    MMW Munch Med Wochenschr; 1974 Jan; 116(1):11-4. PubMed ID: 4204455
    [No Abstract]   [Full Text] [Related]  

  • 12. Counteraction of oxalate induced nitrosative stress by supplementation of l-arginine, a potent antilithic agent.
    Pragasam V; Kalaiselvi P; Sumitra K; Srinivasan S; Varalakshmi P
    Clin Chim Acta; 2005 Apr; 354(1-2):159-66. PubMed ID: 15748613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mild metabolic hyperoxaluria and its response to pyridoxine.
    Gill HS; Rose GA
    Urol Int; 1986; 41(5):393-6. PubMed ID: 3811039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [5-year clinical experience with the kidney calculi solvent Magurlit].
    Baranyai E; Kis E; Szebeni R
    Orv Hetil; 1979 Jul; 120(30):1823-4. PubMed ID: 382037
    [No Abstract]   [Full Text] [Related]  

  • 15. [Drug therapy in urinary calculi. II. Peroral litholysis and prevention].
    Terhorst B; Melchior H
    Urol Int; 1972; 27(3):230-44. PubMed ID: 5050852
    [No Abstract]   [Full Text] [Related]  

  • 16. Magnesium oxide-pyridoxine therapy for recurrent urolithiasis.
    Nutr Rev; 1976 Jan; 34(1):18-20. PubMed ID: 765895
    [No Abstract]   [Full Text] [Related]  

  • 17. [Iatrogenic oxalic lithiasis caused by pyridoxilate].
    Wolf C; Maistre-Charransol G; Barthelemy C; Ottavioli JN; Thomas E; Thomas J
    Nephrologie; 1985; 6(5):225-7. PubMed ID: 4094636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary hyperoxaluria: effect of treatment with vitamin B6 and shock waves.
    Amato M; Donzelli S; Lombardi M; Salvadori M; Carini M; Selli C; Caudarella R
    Contrib Nephrol; 1987; 58():190-2. PubMed ID: 3691125
    [No Abstract]   [Full Text] [Related]  

  • 19. [Inhibition of calcium oxalate urolithiasis with pyridoxine and magnesium in an experiment].
    Krídl J; Zvara V; Revúsová V; Gratzlová J; Ondrus B
    Bratisl Lek Listy; 1984 Jan; 81(1):21-8. PubMed ID: 6692164
    [No Abstract]   [Full Text] [Related]  

  • 20. Metabolism of pyridoxine in mild metabolic hyperoxaluria and primary hyperoxaluria (type 1).
    Edwards P; Rose GA
    Urol Int; 1991; 47(3):113-7. PubMed ID: 1771698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.